GLAM
VRTX icon

Gardner Lewis Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Gardner Lewis Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,216
Closed -$4.56M – 90
2021
Q1 		$4.56M Sell
21,216
-10,820
-34% -$2.38M 0.82% 47
2020
Q4 		$7.57M Hold
32,036
– – 1.76% 21
2020
Q3 		$8.72M Sell
32,036
-175
-0.5% -$48.3K 1.58% 22
2020
Q2 		$9.35M Sell
32,211
-1,213
-4% -$329K 1.73% 19
2020
Q1 		$7.95M Sell
33,424
-4,092
-11% -$939K 1.32% 21
2019
Q4 		$8.21M Sell
37,516
-6,044
-14% -$1.22M 1.12% 22
2019
Q3 		$7.38M Buy
43,560
+9,633
+28% +$1.7M 1.11% 24
2019
Q2 		$6.22M Sell
33,927
-580
-2% -$101K 0.76% 33
2019
Q1 		$6.35M Buy
34,507
+1,870
+6% +$345K 0.79% 29
2018
Q4 		$5.41M Buy
32,637
+3,583
+12% +$621K 0.49% 33
2018
Q3 		$5.6M Sell
29,054
-150
-0.5% -$26.7K 0.43% 39
2018
Q2 		$4.96M Buy
29,204
+2,520
+9% +$391K 0.38% 42
2018
Q1 		$4.35M Buy
26,684
+7,287
+38% +$1.19M 0.34% 48
2017
Q4 		$2.91M Buy
+19,397
New +$2.87M 0.25% 58
2016
Q2 		– Sell
-28,445
Closed -$2.26M – 121
2016
Q1 		$2.26M Sell
28,445
-725
-2% -$65.6K 0.44% 47
2015
Q4 		$3.67M Buy
29,170
+7,240
+33% +$874K 0.58% 47
2015
Q3 		$2.28M Buy
+21,930
New +$2.82M 0.32% 64

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Gardner Lewis Asset Management's VRTX Position: Q2 2021 in Review

Gardner Lewis Asset Management sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 21,216 shares — an estimated $4.56M sold.

Gardner Lewis Asset Management first reported a position in VRTX in Q3 2015 and held it in 17 quarters. The position peaked at $9.35M in Q2 2020. 976 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

  • Gardner Lewis Asset Management reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 21,216 Vertex Pharmaceuticals shares in Q2 2021, an estimated $4.56M.
  • Gardner Lewis Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2015 and held it in 17 quarters.
  • Gardner Lewis Asset Management's Vertex Pharmaceuticals position peaked at $9.35M in Q2 2020.
  • 976 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.